ACI Formulations PLC announcements
278 Dhaka Stock Exchange announcements for ACI Formulations PLC (ACIFORMULA) since 2008: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (19).
- Resumption after record date
Trading of the shares of the Company will resume on 21.11.2021 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 18.11.2021.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 16.11.2021 to 17.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 18.11.2021.
- (Q1 Un-audited): Consolidated EPS was Tk. 1.17 for July-September 2021 as against Tk. 0.42 for July-September 2020; Cons
(Q1 Un-audited): Consolidated EPS was Tk. 1.17 for July-September 2021 as against Tk. 0.42 for July-September 2020; Consolidated NOCFPS was Tk. (2.25) for July-September 2021 as against Tk. (1.99) for July-September 2020. Consolidated NAV per share was Tk. 67.95 as on September 30, 2021 and Tk. 66.77 as on June 30, 2021. (cont.1)
- (cont. of ACIFORMULA): Consolidated revenue increased by around 21\% over SPLY mainly due to higher sales in CC&PH busin
(cont. of ACIFORMULA): Consolidated revenue increased by around 21\% over SPLY mainly due to higher sales in CC&PH business and Contract Manufacturing Activity. Higher sales along with changes in product mix in CC&PH business, led to increase overall gross profit by 30\% over SPLY whereas overall operating expenses increased by 17.6\% (cont. 2)
The first part of this announcement is missing from the archive. - Q1 Financials
(cont. of ACIFORMULA): In addition to that, lower financing cost mainly due to lower interest rate and efficient & effective utilization of working capital through optimized inventory and receivable management led to higher consolidated profit after tax of Tk. 52.78 Mn against Tk 19.10 Mn of SPLY resulting in higher consolidated EPS and NAV per share. On the other hand, consolidated NOCFPS decreased due to inventory build-up for upcoming 2nd quarter. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 11, 2021 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.
- The Board of Directors has recommended 30% cash and 5% stock dividend for the year ended on June 30, 2021. Date of AGM:
The Board of Directors has recommended 30% cash and 5% stock dividend for the year ended on June 30, 2021. Date of AGM: 26.12.2021, Time: 10:00 AM, Venue: Digital Platform. Record Date: 18.11.2021. The Company has also reported Consolidated EPS of Tk. 4.74, Consolidated NAV per share of Tk. 66.77 and Consolidated NOCFPS of Tk. 13.43 for the year ended on June 30, 2021 as against Tk. 2.06, Tk. 53.38 and Tk. 14.52 respectively for the same period of the previous year. (cont. 1)
- (Continuation news of ACIFORMULA): The Company also has informed that disclosures with regards to Recommendation of Stoc
(Continuation news of ACIFORMULA): The Company also has informed that disclosures with regards to Recommendation of Stock Dividend: (i) Dividend has been recommended out of accumulated profit; (ii) Dividend has not been recommended from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the Company or through reducing paid up capital or through doing anything so that the post-dividend retained earnings become negative or a debit balance; (cont. 2
The first part of this announcement is missing from the archive. - Dividend Declaration
(Continuation news of ACIFORMULA): (iii) Bonus Shares has been recommended for utilizing the retained earnings of the company as Capital for ongoing operations, i.e. working capital. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company on today (31.10.2021) for following its corporate declaration.
- Reschedule of Board Meeting under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2021(today) at 6:30 PM instead of 2:45 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2021 at 2:45 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- (Q3 Un-audited): Consolidated EPS was Tk. 1.56 for January-March 2021 as against Tk. 0.65 for January-March 2020; Consol
(Q3 Un-audited): Consolidated EPS was Tk. 1.56 for January-March 2021 as against Tk. 0.65 for January-March 2020; Consolidated EPS was Tk. 4.04 for July 2020-March 2021 as against Tk. 1.82 for July 2019-March 2020. Consolidated NOCFPS was Tk. 3.73 for July 2020-March 2021 as against Tk. 12.09 for July 2019-March 2020. Consolidated NAV per share was Tk. 55.42 as on March 31, 2021 and Tk. 53.38 as on June 30, 2020. (cont.)
- Q3 Financials
(Continuation news of ACIFORMULA): Reasons for significant deviations: The consolidated revenue grew by around 16% over SPLY propelled by higher sales mainly in CC & PH business. Moreover, effective control over operating expenses coupled with lower financing cost led to higher consolidated profit after tax against SPLY resulting in higher consolidated EPS and NAV per share. On the other hand, consolidated NOCFPS decreased mainly due to inventory build-up for meeting the demand of upcoming quarter. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 24, 2021 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.
- Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 2.06 for October-December 2020 as against Tk. 1.02 for October-December 2019; Consolidated EPS was Tk. 2.48 for July-December 2020 as against Tk. 1.17 for July-December 2019. Consolidated NOCFPS was Tk. 2.19 for July-December 2020 as against Tk. 4.77 for July-December 2019. Consolidated NAV per share was Tk. 53.86 as on December 31, 2020 and Tk. 53.38 as on June 30, 2020.
- As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2021 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2020 to the respective shareholders' Bank Accounts through BEFTN system. The undistributed dividend, if any, (due to non-compatible BEFTN account/absent of routing number in the BO setup) dividend warrant will be distributed through courier service to the registered mailing address of the respective Shareholders.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.